HAE FY 2021 Earnings Report — Haemonetics Corporation Revenue & Financial Results | Market Cap Arena

Haemonetics CorporationHAE

FY 2021 Earnings

Reported May 26, 2021

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2021	Prior Q	FY 2020	QoQ Change	YoY Change
Revenue	$870M	—	$988M	—	-11.9%
Op. Income	$90M	—	$103M	—	-13.2%
Gross Margin	49.2%	—	49.4%	—	-0.1pp
Net Margin	9.1%	—	7.7%	—	1.4pp
EPS (Diluted)	$1.55	—	$1.48	—	4.7%
Free Cash Flow	$72M	—	$109M	—	-34.4%

Revenue Flow

Item	Amount
REVENUE	$870M
Cost of Revenue	$442M
GROSS PROFIT	$428M
R&D Expenses	$41M
Selling & Marketing	$3M
General & Administrative	$261M
SG&A Expenses	$264M
Other Expenses	$34M
Operating Expenses	$339M
Cost & Expenses	$781M
OPERATING INCOME	$90M
Interest Income	$0
Interest Expense	$17M
Other Income/Expenses	-$17M
INCOME BEFORE TAX	$73M
Income Tax Expense	-$7M
Net Income from Continuing Ops	$79M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$79M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$79M
D&A	$84M
EBIT	$100M
EBITDA	$184M
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$870M
Cost of Revenue	$442M
GROSS PROFIT	$428M
R&D Expenses	$41M
Selling & Marketing	$3M
General & Administrative	$261M
SG&A Expenses	$264M
Other Expenses	$34M
Operating Expenses	$339M
Cost & Expenses	$781M
OPERATING INCOME	$90M
Interest Income	$0
Interest Expense	$17M
Other Income/Expenses	-$17M
INCOME BEFORE TAX	$73M
Income Tax Expense	-$7M
Net Income from Continuing Ops	$79M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$79M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$79M
D&A	$84M
EBIT	$100M
EBITDA	$184M
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$79M
Depreciation & Amortization	$84M
Stock-Based Compensation	$26M
Deferred Income Tax	-$20M
Other Non-Cash Items	-$919.0K
Change in Working Capital	-$60M
OPERATING CASH FLOW	$109M
Capital Expenditure	-$37M
Acquisitions (Net)	-$390M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$2M
NET CASH FROM INVESTING	-$425M
Net Debt Issuance	$418M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	-$51M
NET CASH FROM FINANCING	$367M
FREE CASH FLOW	$72M
Net Change in Cash	$55M

Balance Sheet

Item	Amount
Cash & Equivalents	$192M
Short-Term Investments	$0
Net Receivables	$128M
Inventory	$323M
Other Current Assets	$0
TOTAL CURRENT ASSETS	$694M
PP&E (Net)	$218M
Goodwill	$466M
Intangible Assets	$365M
Long-Term Investments	$0
Tax Assets	$6M
Other Non-Current Assets	$71M
TOTAL NON-CURRENT ASSETS	$1.1B
TOTAL ASSETS	$1.8B
Account Payables	$50M
Short-Term Debt	$17M
Deferred Revenue	$26M
Other Current Liabilities	$81M
TOTAL CURRENT LIABILITIES	$253M
Long-Term Debt	$691M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$44M
Other Non-Current Liabilities	$37M
TOTAL NON-CURRENT LIABILITIES	$835M
TOTAL LIABILITIES	$1.1B
Common Stock	$509.0K
Additional Paid-In Capital	$603M
Retained Earnings	$158M
Treasury Stock	$0
Accum. Other Comp. Income	-$30M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$732M
Minority Interest	$0
TOTAL EQUITY	$732M
TOTAL LIABILITIES & EQUITY	$1.8B
Total Debt	$778M
Net Debt	$586M